The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.

The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

The Federal Trade Commission said on Friday that it had taken legal action against the three largest pharmacy benefit ...

Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.

The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...

UnitedHealth Group division calls the action “baseless” and shows “profound misunderstanding” of drug pricing.

The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, ...

The Federal Trade Commission said the three companies' practices have artificially inflated list prices for insulin.

The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes ...